Results 211 to 220 of about 1,598,142 (264)

Prion protein (PrP) profiles in blood and CSF: insights into pre-symptomatic and symptomatic prion disease. [PDF]

Brain Commun
Laginha I, Schmitz M, da Silva Correia Â, Saleem T, da Silva Correia S, Zafar S, Younas N, Canaslan S, Göbel S, Root E, Breitbarth M, Fischer AL, Dittmar K, Žakova D, Hermann P, Zerr I.   +15 more
europepmc   +1 more source

TDP-43 Aggregation: The Healthy-Toxic Balance of the Prion-Like Domain. [PDF]

Adv Sci (Weinh)
Zangrando L, Buratti E, Paron F.
europepmc   +1 more source

Chemo-omic pipeline enables discovery of prion synaptotoxic pathways and inhibitory drugs. [PDF]

PLoS Pathog
Le NTT, Mercer RCC, Fang C, Sundaravadivelu A, Labadorf AT, Lin W, Kwan J, Blum B, Emili A, Harris DA.   +9 more
europepmc   +1 more source

NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. [PDF]

, 2010
Legname, G, Giachin, G, Jaremko, Łukasz, Jaremko, Mariusz   +3 more
core   +1 more source

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases. [PDF]

Neurology
Coysh T, Laban R, Veleva E, Heslegrave AJ, Darwent L, Holm-Mercer L, Mok TH, Hart MS, Lunn MP, Keshavan A, Schott JM, Jaunmuktane Z, Brandner S, Gonzalez-Ortiz F, Blennow K, Zetterberg H, Collinge J, Mead S.   +17 more
europepmc   +1 more source

Generation of Infectious Prions Amenable to Site-Specific Click Chemistry. [PDF]

ACS Chem Biol
Campbell RG, Iseler JN, Schwind AM, Supattapone S.   +3 more
europepmc   +1 more source

PrP^C-facilitated cell signaling activates phospholipase Cɣ1 and triggers an Arc/Arg3.1 response in mouse and iPSC-derived human neurons. [PDF]

Stem Cell Reports
Ojeda-Juarez D, Funk G, McClatchy DB, Richards E, Rajic AJ, Soldau K, Geschwind MD, Chen X, Yates JR, Gonias SL, Sigurdson CJ.   +10 more
europepmc   +1 more source

Preclinical serum alterations and tissue changes in protein and gene expression of early cerebrospinal fluid-validated biomarkers in scrapie. [PDF]

Vet Res
Pérez-Lázaro S, Barrio T, Sevilla E, Bolea R, Badiola JJ.   +4 more
europepmc   +1 more source

Therapeutic strategies in prion disease: current evidence, translational challenges, and emerging directions. [PDF]

Front Neurosci
Zhu Y, Bradford BM, Mabbott NA.
europepmc   +1 more source

FIS1 dependent peripheral fission exacerbates mitochondrial fragmentation and dysfunction in prion diseases. [PDF]

Front Neurosci
Gou F, Li Z, Li J, Yang D, Zhao M, Wang D, Wen P, Sun Z, Wang J, Fan Q, Dai Y, Zhao D, Yang L.   +12 more
europepmc   +1 more source